ATNF Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.17%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

180 Life Sciences Insider Trading History Chart

180 Life Sciences Share Price & Price History

^$0.87

▼ -0.012 (-1.36%)

As of 04/4/2025 04:45 PM ET

Days: 30 | 90 | 365

180 Life Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/31/2023	Donald A. McGovern, Jr.	Director	Buy	526	$21.85	$11,493.10	1,584
5/18/2023	James N. Woody	CEO	Buy	2,105	$19.57	$41,194.85	2,204
5/18/2023	Ozan Pamir	CFO	Buy	271	$19.19	$5,200.49	472
5/18/2023	Pamela G Marrone	Director	Buy	372	$20.14	$7,492.08	656

SEC Filings (Institutional Ownership Changes) for 180 Life Sciences (NASDAQ:ATNF)

4.07% of 180 Life Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

180 Life Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Anson Funds Management LP	225,271	$0.41M	0.0%	N/A	7.084%
2/13/2025	Rathbones Group PLC	69,995	$0.13M	0.0%	N/A	2.201%
11/15/2023	Armistice Capital LLC	131,000	$80K	0.0%	N/A	2.462%
11/14/2022	Armistice Capital LLC	3,915,000	$2.60M	0.0%	N/A	11.466%
2/10/2022	Citizens Financial Group Inc RI	131,775	$0.51M	0.0%	N/A	0.387%
2/10/2022	Rathbones Group PLC	50,000	$0.20M	0.0%	N/A	0.147%
11/9/2021	BlackRock Inc.	240,813	$1.30M	0.0%	-9.5%	0.718%
11/5/2021	First National Trust Co	19,000	$0.10M	0.0%	N/A	0.057%
10/19/2021	Belvedere Trading LLC	51,544	$0.31M	0.0%	-23.5%	0.153%
9/17/2021	Virtu Financial LLC	25,495	$0.26M	0.0%	-13.2%	0.076%
9/7/2021	Newbridge Financial Services Group Inc.	3,000	$30K	0.0%	N/A	0.009%
8/16/2021	Pinz Capital Management LP	12,100	$0.12M	0.0%	+119.6%	0.039%
8/16/2021	State Street Corp	63,426	$0.63M	0.0%	N/A	0.206%
8/13/2021	Northern Trust Corp	29,068	$0.29M	0.0%	+13.4%	0.094%
8/13/2021	Murchinson Ltd.	95,276	$0.95M	0.3%	N/A	0.310%
8/13/2021	Geode Capital Management LLC	123,049	$1.23M	0.0%	-5.9%	0.400%
8/13/2021	Vanguard Group Inc.	390,260	$3.90M	0.0%	-22.2%	1.268%
8/11/2021	BlackRock Inc.	266,016	$2.66M	0.0%	+3.3%	0.865%
5/19/2021	Virtu Financial LLC	29,372	$0.19M	0.0%	N/A	0.163%
5/17/2021	HRT Financial LP	17,590	$0.12M	0.0%	N/A	0.098%
5/17/2021	Pinz Capital Management LP	5,510	$36K	0.0%	N/A	0.031%
5/14/2021	Credit Suisse AG	10,300	$68K	0.0%	N/A	0.057%
5/12/2021	Geode Capital Management LLC	130,695	$0.86M	0.0%	N/A	0.725%
5/7/2021	BlackRock Inc.	257,396	$1.69M	0.0%	N/A	1.427%
5/6/2021	First National Trust Co	12,000	$79K	0.0%	N/A	0.067%
4/28/2021	Mizuho Securities USA LLC	52,400	$0.34M	0.0%	N/A	0.291%

Data available starting January 2016

See Full Table

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.

Today's Range

Now: $0.87

$0.83

$0.87

50 Day Range

MA: $1.21

$0.87

$1.54

52 Week Range

Now: $0.87

$0.83

$17.75

Volume

19,579 shs

Average Volume

794,384 shs

Market Capitalization

$2.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.27

Who are the company insiders with the largest holdings of 180 Life Sciences?: 180 Life Sciences' top insider investors include:
James N Woody (CEO)
Jr Donald A Mcgovern (Director)
Pamela G Marrone (Director)
Ozan Pamir (CFO)
Learn More about top insider investors at 180 Life Sciences.